Mechanism of action, clinical effectiveness, and optimal therapeutic range

被引：358

作者：

Hirsh, J ^{[1
]}

Dalen, JE ^{[1
]}

Anderson, DR ^{[1
]}

Poller, L ^{[1
]}

Bussey, H ^{[1
]}

Ansell, J ^{[1
]}

Deykin, D ^{[1
]}

Brandt, JT ^{[1
]}

机构：

[1] Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada

来源：

CHEST | 1998年 / 114卷 / 05期

关键词：

D O I：

10.1378/chest.114.5_Supplement.445S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

收藏

页码：445S / 469S

页数：25

相关论文

共 250 条

[31] BROEKMANS AW, 1983, THROMB HAEMOSTASIS, V49, P251
[32] HEMOSTATIC DEFECT PRODUCED BY CARBENICILLIN
BROWN, CH
NATELSON, EA
BRADSHAW, MW
WILLIAMS, TW
ALFREY, CP
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (06) : 265 - 270
[33] RELIANCE ON PROTHROMBIN TIME RATIOS CAUSES SIGNIFICANT ERRORS IN ANTICOAGULATION THERAPY
BUSSEY, HI
FORCE, RW
BIANCO, TM
LEONARD, AD
[J]. ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (02) : 278 - 282
[34] BUSSEY HI, 1989, PHARMACOTHERAPY, V9, P214
[35] ANTITHROMBOTIC AGENTS IN CORONARY-ARTERY DISEASE
CAIRNS, JA
HIRSH, J
LEWIS, HD
RESNEKOV, L
THEROUX, P
[J]. CHEST, 1992, 102 (04) : S456 - S481
[36] OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES
CANNEGIETER, SC
ROSENDAAL, FR
WINTZEN, AR
VANDERMEER, FJM
VANDENBROUCKE, JP
BRIET, E
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) : 11 - 17
[37] CAZENAVE JP, 1973, P SOC EXP BIOL MED, V142, P159
[38] CHANTARANGKUL V, 1995, THROMB HAEMOSTASIS, V73, P1237
[39] ANTICOAGULATION CLINICS AND THE MONITORING OF ANTICOAGULANT-THERAPY
CHARNEY, R
LEDDOMADO, E
ROSE, DN
FUSTER, V
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1988, 18 (02) : 197 - 206
[40] TRIAL OF COMBINED WARFARIN PLUS DIPYRIDAMOLE OR ASPIRIN THERAPY IN PROSTHETIC HEART-VALVE REPLACEMENT - DANGER OF ASPIRIN COMPARED WITH DIPYRIDAMOLE
CHESEBRO, JH
FUSTER, V
ELVEBACK, LR
MCGOON, DC
PLUTH, JR
PUGA, FJ
WALLACE, RB
DANIELSON, GK
ORSZULAK, TA
PIEHLER, JM
SCHAFF, HV
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (09) : 1537 - 1541

← 1 2 3 4 5 6 7 8 9 10 →